What is Bristol-Myers Squibb's other working capital?

Bristol-Myers Squibb (BMY) reported other working capital of $1.64B in Q1 2026.

How has Bristol-Myers Squibb's other working capital changed year-over-year?

Bristol-Myers Squibb's other working capital increased by 54.5% year-over-year, from $1.06B to $1.64B.

What does other working capital mean?

Net change in working capital items not separately classified — a residual balancing item.

Bristol-Myers Squibb BMY Other Working Capital

Other Working Capital at other companies

IncyteINCY

-$12.77M-141%

Neurocrine BiosciencesNBIX

$0-100%

ImmunityBio, Inc.IBRX

$16K-93.4%

Protagonist TherapeuticsPTGX

-$2K-140%

AlkermesALKS

-$717K-135%

Arcus BiosciencesRCUS

$1M—

Other financials

Income statement

See full

Revenue$11.5B+2.6%

Gross profit$8.1B-1.2%

Net income$2.7B+9.0%

EPS (diluted)$1.31+9.2%

Balance sheet

See full

Cash & equivalents$9.6B-12.0%

Total debt$44.7B-10.5%

Total equity$20.1B+15.4%

Total assets$86.5B-6.4%

Cash flow

See full

Operating cash flow$1.1B-43.5%

CapEx$347.0M+33.5%

Free cash flow$757.0M-55.3%

Valuation

See full

Market cap$117.66B+25.0%

Enterprise value$152.75B+16.8%

P/E16.2×-2.7×

P/S2.4×+0.5×

Profitability

See full

Gross margin70.5%0.0pp

Net margin15%+3.8pp

FCF margin24.6%-2.9pp

Returns & leverage

See full

Return on equity38.8%+7.3pp

Debt / equity2.2×-0.6×

Current ratio1.4×+0.1×

Where this comes from

Reported directly by Bristol-Myers Squibb in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet.

The official record: Bristol-Myers Squibb’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bristol-Myers Squibb's other working capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bristol-Myers Squibb's other working capital?: Bristol-Myers Squibb (BMY) reported other working capital of $1.64B in Q1 2026.
How has Bristol-Myers Squibb's other working capital changed year-over-year?: Bristol-Myers Squibb's other working capital increased by 54.5% year-over-year, from $1.06B to $1.64B.
What does other working capital mean?: Net change in working capital items not separately classified — a residual balancing item.